Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (4): 599-604. doi: 10.19723/j.issn.1671-167X.2022.04.004

Previous Articles     Next Articles

Effects of 4′-O-methylochnaflavone on endothelial dysfunction induced by palmitic acid in rat cavernous endothelial cells

Yang-yang GU1,Xiao-hui TAN1,Wen-peng SONG1,Dong FANG1,Wei-dong SONG1,Yi-ming YUAN1,Ning-han FENG2,*(),Rui-li GUAN1,*()   

  1. 1. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; Beijing 100034, China
    2. Department of Urology, Wuxi Second Hospital, Nanjing Medical University, Wuxi 214002, Jiangsu, China
  • Received:2022-03-25 Online:2022-08-18 Published:2022-08-11
  • Contact: Ning-han FENG,Rui-li GUAN E-mail:n.feng@njmu.edu.cn;guanruili@bjmu.edu.cn
  • Supported by:
    the National Natural Science Foundation of China(81971379);the Wuxi "Taihu Talents Program" Medical and Health High-Level Talents Project

Abstract:

Objective: To investigate the effect of biflavonoid 4′-O-methylochnaflavone (MF) on palmitic acid-induced endothelial dysfunction in rat cavernous endothelial cells (RCECs). Methods: The isolated RCECs were commercially available and randomly divided into four groups: normal+BSA group (NC group), palmitic acid (PA) group, MF group, and icariside Ⅱ (ICA Ⅱ) group. The protein expression levels of protein kinase B (PKB/AKT) and endothelial nitric oxide synthase (eNOS) in each group were evaluated via Western blotting. The differences in the intracellular nitric oxide of RCECs treated by MF or ICA Ⅱ were detected by DAF-FM DA that served as a nitric oxide fluorescent probe. Effects of MF and ICA Ⅱ on cell proliferation of PA-stimulated RCECs were determined via CCK-8 assay. Results: The content of nitric oxide in RCECs was significantly increased after the treatment of MF and ICA Ⅱ in comparison with the NC group (P < 0.05). Moreover, compared with ICA Ⅱ group, MF demonstrated a more obvious effect in promoting nitric oxide production (P < 0.05). Compared with the NC group, the expression levels of eNOS and AKT in the PA group were significantly decreased, indicating that a model for simulating the high-fat environment in vitro was successfully constructed (P < 0.05). Meanwhile, the intervention of MF and ICA Ⅱ could effectively increase the expression of eNOS and AKT, suggesting that MF and ICA Ⅱ could promote the recovery of endothelial dysfunction caused by high levels of free fatty acids (P < 0.05). The results of CCK-8 assays showed that PA could significantly reduce the proli-feration ability of RCECs (P < 0.05). Furthermore, the decreased cell viability induced by PA was significantly elevated by treatment with ICA Ⅱ and MF (P < 0.05). Conclusion: In RCECs, MF and ICA Ⅱ could effectively increase the content of nitric oxide. The down-regulation of the expression of proteins associated with the AKT/eNOS pathway after PA treatment revealed that this pathway was involved in the development of endothelial dysfunction, which could be effectively reversed by MF and ICA Ⅱ. In addition, the cell proliferation ability was significantly decreased following PA treatment, but MF and ICA Ⅱ could restore the above changes. Overall, biflavonoid MF has an obvious repairing effect on PA-stimulated endothelial dysfunction.

Key words: Endothelial dysfunction, Palmitic acid, Nitric oxide synthase, Signal transduction

CLC Number: 

  • R698.1

Figure 1

Chemical structure of 4′-O-methylochnaflavone and icariside Ⅱ"

Figure 2

The evaluation of intracellular NO following the treatment of MF and ICA Ⅱ"

Figure 3

The protein level of eNOS and AKT following the treatment of PA PA, palmitic acid; AKT, protein kinase B; eNOS, endothelial nitric oxide synthase. *P < 0.05."

Figure 4

The protein level of eNOS and AKT in the PA-stimulated cells following the treatment of MF and ICA Ⅱ NC, normal control; PA, palmitic acid; MF, 4′-O-methylochnaflavone; ICA Ⅱ, icariside Ⅱ; AKT, protein kinase B; eNOS, endothelial nitric oxide synthase. *P < 0.05."

Figure 5

The RCECs proliferation ability of the PA-stimulated cells following the treatment of MF and ICA Ⅱ A, the RCECs were treated with different concentrations of MF and ICA Ⅱ for 24 h with cell viability measured via the CCK-8 assay; B, the RCECs were treated with 150 μmol/L PA in the presence or absence of MF and ICA Ⅱ for 24 h with cell viability measured via the CCK-8 assay. CCK, cell counting kit; NC, normal control; PA, palmitic acid; MF, 4′-O-methylochnaflavone; ICA Ⅱ, icariside Ⅱ; RCECs, rat cavernous endothelial cells; NS, no significant; μM, μmol/L; ***P < 0.001."

1 Bakr AM , El-Sakka AI . Erectile dysfunction among patients and health care providers during COVID-19 pandemic: A systematic review[J]. Int J Impot Res, 2022, 34 (2): 145- 151.
doi: 10.1038/s41443-021-00504-w
2 Yafi FA , Jenkins L , Albersen M , et al. Erectile dysfunction[J]. Nat Rev Dis Primers, 2016, 2, 16003.
doi: 10.1038/nrdp.2016.3
3 Ghosh A , Gao L , Thakur A , et al. Role of free fatty acids in endothelial dysfunction[J]. J Biomed Sci, 2017, 24 (1): 50.
doi: 10.1186/s12929-017-0357-5
4 Zhao Y , Vanhoutte PM , Leung SWS . Vascular nitric oxide: Beyond eNOS[J]. J Pharmacol Sci, 2015, 129 (2): 83- 94.
doi: 10.1016/j.jphs.2015.09.002
5 Boden G . Obesity and free fatty acids[J]. Endocrin Metab Clin, 2008, 37 (3): 635- 646.
doi: 10.1016/j.ecl.2008.06.007
6 Egan BM , Greene EL , Goodfriend TL . Nonesterified fatty acids in blood pressure control and cardiovascular complications[J]. Curr Hypertens Rep, 2001, 3 (2): 107- 116.
doi: 10.1007/s11906-001-0021-y
7 Haus JM , Solomon TPJ , Marchetti CM , et al. Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance[J]. J Clin Endocr Metab, 2010, 95 (1): 323- 327.
doi: 10.1210/jc.2009-1101
8 Durrant JR , Seals DR , Connell ML , et al. Voluntary wheel running restores endothelial function in conduit arteries of old mice: Direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase[J]. J Physiol, 2009, 587 (13): 3271- 3285.
doi: 10.1113/jphysiol.2009.169771
9 Khan MJ , Rizwan Alam M , Waldeck-Weiermair M , et al. Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells[J]. J Biol Chem, 2012, 287 (25): 21110- 21120.
doi: 10.1074/jbc.M111.319129
10 Lee C , Lee S , Ou H , et al. Eicosapentaenoic acid protects against palmitic acid-induced endothelial dysfunction via activation of the AMPK/eNOS pathway[J]. Int J Mol Sci, 2014, 15 (6): 10334- 10349.
doi: 10.3390/ijms150610334
11 Wang L , Xu Y , Li H , et al. Antioxidant icariside Ⅱ combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats[J]. J Cell Mol Med, 2015, 19 (5): 960- 969.
doi: 10.1111/jcmm.12480
12 Gu S J , Li M , Yuan YM , et al. A novel flavonoid derivative of icariside Ⅱ improves erectile dysfunction in a rat model of caver-nous nerve injury[J]. Andrology, 2021, 9 (6): 1893- 1901.
doi: 10.1111/andr.13065
13 Godo S , Shimokawa H . Endothelial functions[J]. Arterioscler Thromb Vasc Biol, 2017, 37 (9): e108- e114.
14 Chlopicki S . Perspectives in pharmacology of endothelium: From bench to bedside[J]. Pharmacol Rep, 2015, 67 (4): vi- ix.
doi: 10.1016/j.pharep.2015.08.005
15 Everaert BR , van Craenenbroeck EM , Hoymans VY , et al. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: Focus on Pi3K/AKT/eNOS pathway[J]. Int J Cardiol, 2010, 144 (3): 350- 366.
doi: 10.1016/j.ijcard.2010.04.018
16 Morris G , Puri BK , Olive L , et al. Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments[J]. BMC Med, 2020, 18 (1): 305.
doi: 10.1186/s12916-020-01749-w
17 Mu H , Liu H , Zhang J , et al. Ursolic acid prevents doxorubicin-induced cardiac toxicity in mice through eNOS activation and inhibition of eNOS uncoupling[J]. J Cell Mol Med, 2019, 23 (3): 2174- 2183.
doi: 10.1111/jcmm.14130
18 Schmitt CA , Dirsch VM . Modulation of endothelial nitric oxide by plant-derived products[J]. Nitric Oxide, 2009, 21 (2): 77- 91.
19 García-Prieto CF , Hernández-Nuño F , Rio DD , et al. High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway[J]. Mol Nutr Food Res, 2015, 59 (3): 520- 532.
doi: 10.1002/mnfr.201400539
20 Vadivel V , Kunyanga CN , Biesalski HK . Health benefits of nut consumption with special reference to body weight control[J]. Nutrition, 2012, 28 (11/12): 1089- 1097.
21 Brookheart RT , Michel CI , Schaffer JE . As a matter of fat[J]. Cell Metab, 2009, 10 (1): 9- 12.
doi: 10.1016/j.cmet.2009.03.011
22 Wang M , Gao H , Li W , et al. Icariin and its metabolites regulate lipid metabolism: From effects to molecular mechanisms[J]. Biomed Pharmacother, 2020, 131, 110675.
23 Li H , Xu Y , Guan R , et al. Icariside Ⅱ prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway[J]. Andrology, 2015, 3 (2): 408- 416.
24 Lee S J , Choi JH , Son KH , et al. Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids[J]. Life Sci, 1995, 57 (6): 551- 558.
25 Li L , Ma L , Hu Y , et al. Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease[J]. Phytochemistry, 2022, 193, 112984.
[1] LI Zheng,WANG Xiao,HONG Tian-pei,WANG Hao-jie,GAO Zhan-yi,WAN Meng. Mechanism of advanced glycation end products inhibiting the proliferation of peripheral blood mononuclear cells and osteoblasts in rats [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 355-363.
[2] GUO Qian, CHEN Xu-yong, SU Yin. Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 1100-1104.
[3] XIAO Yang, DU Yao-yao, GAO Cheng, KONG Wei. Dynamic alteration of microRNA in high phosphorus induced calcification of vascular smooth muscle cell [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 756-765.
[4] CAO Pei, JIANG Xue-jun, XI Zhi-jun. Sunitinib induces autophagy via suppressing Akt/mTOR pathway in renal cell carcinoma [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 584-589.
[5] WANG Zhu-Qing, WANG Ping, WU-CHOU Yah-huei, YE Xiao-Qian, HUANG Shang-Zhi, SHI Bing, WANG Ke, YUAN Yuan, LIU Dong-Jing, WU Tao, WANG Hong, Terri H. Beaty. Association study between candidate genes on transforming growth factor-β signaling pathway and the risk of non-syndromic cleft lip with or without cleft palate in Chinese populations [J]. Journal of Peking University(Health Sciences), 2015, 47(3): 384-389.
[6] Li-Jing-Jin, CHEN Hong, REN Jing-Yi. Targeted effect of microRNA on nerve growth factor pathway and its functional network in patients with unstable angina [J]. Journal of Peking University(Health Sciences), 2014, 46(6): 868-874.
[7] CHANG Si-jia, ZOU Xiao-ying, ZHUANG Heng, YUE Lin, GAO Xue-jun. Notch activation delayed ageing of human dental pulp cells [J]. Journal of Peking University(Health Sciences), 2014, 46(1): 5-11.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2001, 33(2): 181 -182 .
[2] . [J]. Journal of Peking University(Health Sciences), 2007, 39(6): 663 -665 .
[3] . [J]. Journal of Peking University(Health Sciences), 2008, 40(1): 39 -42 .
[4] . [J]. Journal of Peking University(Health Sciences), 2008, 40(5): 551 -554 .
[5] . [J]. Journal of Peking University(Health Sciences), 2003, 35(3): 307 -310 .
[6] . [J]. Journal of Peking University(Health Sciences), 2002, 34(1): 64 -67 .
[7] . [J]. Journal of Peking University(Health Sciences), 2001, 33(5): 457 -461 .
[8] . [J]. Journal of Peking University(Health Sciences), 2008, 40(4): 369 -373 .
[9] . [J]. Journal of Peking University(Health Sciences), 2010, 42(2): 126 -130 .
[10] . [J]. Journal of Peking University(Health Sciences), 2003, 35(5): 499 -502 .